Dentists in Macomb, IL Accepting Medicare

8 Dentists found. Showing 1 - 8

Tonny Jill Williamson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 528 W. Jackson St., Macomb, IL 61455 Phone: 309-837-7727    Fax: 309-836-7801

Matthew Scott Mcclure, D.M.D., P.C. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1508 E Jackson St, Macomb, IL 61455 Phone: 309-837-2633    Fax: 309-833-4554

Dr. Richard W Passmore, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 233 S Mcarthur St, Macomb, IL 61455 Phone: 309-833-1766    Fax: 309-836-9871

Dr. Nicholas D Doll, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1400 E Carroll St, Suite B, Macomb, IL 61455 Phone: 309-421-3163

Dr. Jon Karl Dively, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 4 Doctors Ln, Macomb, IL 61455 Phone: 309-837-3918

Jerald A. Spolar, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 528 W Jackson St, Macomb, IL 61455 Phone: 309-837-7727    Fax: 309-836-7801

Timothy Robert Fitzgerald, DDS Dentist Medicare: Medicare Enrolled Practice Location: 335 W Jackson Street, Macomb, IL 61455 Phone: 309-833-2125

Theodore James Pawlias, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 501 East Grant Street, Unit #3, Macomb, IL 61455 Phone: 309-837-6344    Fax: 309-837-6344

News Archive

Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

Rapid generation of divergent synthetic antibodies against SARS-CoV-2 in a cell-free engineering platform

In a groundbreaking bioRxiv paper, a research group from the Massachusetts Institute of Technology (MIT), Harvard University and Howard Hughes Medical Institute in the US engineered antibodies against the receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein by using a novel approach. In doing so, they also identified more than 800 predicted binder families.

Mylan receives FDA approval for generic Imitrex

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility.

BioMimetic Therapeutics reports net loss of $7.7M for second-quarter 2010

BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.

Non-contact IR thermometers fail for COVID-19 temperature screening, say physicians

While a fever is one of the most common symptoms for people who get sick with COVID-19, taking one's temperature is a poor means of screening who is infected with the SARS-CoV-2 virus that causes the disease, and more importantly, who might be contagious.

Read more Medical News

› Verified 1 days ago